Johannes Putze
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Traditional plant urologicals curb early uropathogenic E. coli infection and strengthen host innate defense.
Journal: Applied microbiology and biotechnology
Published: October 28, 2025
Two Polyketides Intertwined in Complex Regulation: Posttranscriptional CsrA-Mediated Control of Colibactin and Yersiniabactin Synthesis in Escherichia coli.
Journal: mBio
Published: February 01, 2022
Active bacterial modification of the host environment through RNA polymerase II inhibition.
Journal: The Journal of clinical investigation
Published: May 18, 2020
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer.
Journal: Nature biotechnology
Published: August 27, 2019
Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens.
Journal: Frontiers in microbiology
Published: December 16, 2017
Gaining Access to Bacteria through (Reversible) Control of Lipophilicity.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: September 26, 2017
Uropathogenic E. coli Exploit CEA to Promote Colonization of the Urogenital Tract Mucosa.
Journal: PLoS pathogens
Published: August 28, 2014
Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.
Journal: Infection and immunity
Published: August 27, 2014
Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines.
Journal: Nutrition research (New York, N.Y.)
Published: May 08, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026